Quote:
Originally Posted by PhiGam
|
That was really interesting. It's a little disappointing that the treatment, when given for leukemia, kills 30% of its patients, but it is a new avenue of hope.
I also wonder why there's no widespread promotion of testing to see if people have the mutation that prevents infection. And it's interesting to wonder why, as uncommon as it is, why it's more common in Northern Europeans. What was the evolutionary issue?
Threaded Mode
